WO2000050100A1 - Composite super elastic/shape memory alloy and malleable alloy stent - Google Patents

Composite super elastic/shape memory alloy and malleable alloy stent Download PDF

Info

Publication number
WO2000050100A1
WO2000050100A1 PCT/US2000/004987 US0004987W WO0050100A1 WO 2000050100 A1 WO2000050100 A1 WO 2000050100A1 US 0004987 W US0004987 W US 0004987W WO 0050100 A1 WO0050100 A1 WO 0050100A1
Authority
WO
WIPO (PCT)
Prior art keywords
copper
stent
zinc
nickel
titanium
Prior art date
Application number
PCT/US2000/004987
Other languages
French (fr)
Inventor
William J. Boyle
Original Assignee
Advanced Cardiovascular Systems, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Cardiovascular Systems, Inc. filed Critical Advanced Cardiovascular Systems, Inc.
Priority to AU37091/00A priority Critical patent/AU3709100A/en
Priority to JP2000600710A priority patent/JP2002537072A/en
Priority to EP00915894A priority patent/EP1152775A1/en
Publication of WO2000050100A1 publication Critical patent/WO2000050100A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/12Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L31/121Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix
    • A61L31/124Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix of other specific inorganic materials not covered by A61L31/122 or A61L31/123
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91575Adjacent bands being connected to each other connected peak to trough
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0076Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0013Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0048Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in mechanical expandability, e.g. in mechanical, self- or balloon expandability

Definitions

  • the present invention relates to expandable endoprosthesis devices, generally called stents, that are adapted to be implanted into a patient's body lumen, such as a blood vessel, to maintain the patency thereof.
  • stents that are adapted to be implanted into a patient's body lumen, such as a blood vessel, to maintain the patency thereof.
  • the invention relates to metallic stents formed from a composite structure comprising discrete layers of super elastic or shape memory alloys and biocompatible, malleable alloys.
  • Stents are generally cylindrically shaped devices that function to hold open and sometimes expand a segment of a blood vessel or other anatomical lumen. Stents particularly are suitable for use to support and hold back a dissected arterial lining which can occlude the fluid passageway therethrough, or to maintain the patency of a portion of a blood vessel that has been subjected to an angioplasty procedure.
  • a variety of devices are known in the art for use as stents and have included coiled wires, slotted tubes, and adjacently connected cylindrical elements in a variety of patterns that are expanded after being placed intraluminaly on a balloon catheter; helically-wound coiled springs manufactured from a thermally expandable metal; and self-expanding stents inserted in a compressed state and subsequently allowed to expand at the intraluminal target site by withdrawing the compressive force, such as provided by an overlying sheath.
  • a stent structure that is longitudinally flexible to easily traverse the tortuous pathways of the human vasculature and which can be readily and uniformly expanded, but that will resist permanent deformation due to the compressive forces exerted by the body lumen itself or by external forces on the body lumen once the stent is deployed and expanded. Resistance to permanent deformation can be especially desirable, for example, in stents deployed within a patient's carotid artery, where a stent may be subjected to additional forces generated by the patient's head and neck movements, or by the pillow, arm, or other head rest used by the patient when sleeping, or by blows to the patient's neck or head.
  • U.S. Pat. No. 5,749,880 to Banas et al. discloses a stent-graft comprising a tubular stent structure with openings through its wall surfaces to permit radial expansion and circumferentially adjacent layers of polytetrafluoroethylene (ePTFE) covering the inner and outer wall surfaces of the stent.
  • ePTFE polytetrafluoroethylene
  • the ePTFE coverings are sintered to the tubular stent to bond around and through the wall surfaces of the tubular stent.
  • the ePTFE coverings expand as well to prevent exposing the stent to body tissue or fluids.
  • the goal of this stent therefore is to enhance the biocompatibility of the stent rather than to enhance its mechanical properties.
  • U.S. Patent No. 5,725,570 to Heath discloses tubular prostheses that are woven from a filament consisting of a metal outer layer with an exposed outer surface and an inner core comprised of a different material than the outer layer.
  • the outer layer is selected from superelastic alloys such as nickel-titanium (nitinol) or stainless steel, and the core is a high density, radiopaque metal such as tantalum.
  • Stents formed from such a filament are said to exhibit substantially the elasticity properties of a solid nitinol filament, but with higher radiopacity.
  • such a filament does not impart increased structural strength to the filament, and does not alleviate problems associated with woven wire stents such as lower than desirable crush resistance.
  • the filament experiences a wide range of tension and compression as it is bent during weaving and placement of the stent, as well as during use. These forces are experienced to different degrees by the inner core and the outer layer and could be a potential source of failure due to the different responses exhibited by the dissimilar metals in the core and in the outer layer.
  • Another type of device is, for example, disclosed in U.S. Patent No. 5,769,882 to Fogarty et al, and comprises essentially a tubular prosthesis body with an overlying sealing layer to provide a fluid-tight seal between the exterior surface of the prosthesis and the inner wall of the body lumen.
  • the tubular body is disclosed as being comprised of two or more different materials, such as organic polymers and metallic elements, to provide different characteristics to the body, such as shape memory, drug delivery, bioabsorbability, and radiopaqueness.
  • the specification discloses that such different materials can be incorporated in a variety of ways, such as different interwoven helices and braids, and include tantalum, nitinol, polyester, and PTFE. Again, this type of device appears limited to woven structures, and is directed to structures wherein the individual filaments are comprised of a single homogeneous material. Further, this type of device does not appear to address the goal of increased structural strength.
  • the present invention addresses the above-mentioned needs by providing a tubular stent structure manufactured from a metallic tube comprising one or more layers of a biocompatible, malleable material co-drawn with, or compression fit onto, one or more layers of a superelastic, or shape memory alloy, material.
  • the stent is manufactured by forming various patterns into the wall of the tube to create radially expandable, interconnected elements. The patterns may be formed by various methods, such as laser cutting, mechanical grinding or chemical etching, or a combination of these methods.
  • the stent is introduced into the vasculature of the patient and deployed at the target site using well-known balloon angioplasty techniques.
  • the stent Once expanded, the stent exhibits, due to the malleable material layer, structural strength and crush resistance to support the vascular wall and to maintain the patency of the vessel.
  • the stent additionally exhibits enhanced resistance to permanent deformation due to the superelastic material layer that proceeds to spring back to a predetermined expanded size and shape whenever subjected to a compressive force.
  • a stent formed according to the method of the present invention provides an axially flexible structure that, when expanded, offers radial strength and superior resistance to permanent deformation.
  • the stent is manufactured economically using known methods and materials, and comprises a significant improvement to the long-term safety of stents and stent-like devices.
  • FIGURE 1 is a cross-sectional view depicting a tube for making a stent according to the present invention
  • FIG. 2 is a plan view depicting a flattened section of a stent pattern made according to the present invention.
  • FIG. 3 is a plan view depicting a flattened section of an alternative embodiment stent pattern made according to the present invention.
  • a cylindrical tube 10 is comprised of a co-drawn outer layer 30 and an inner layer 32.
  • the embodiment of the cylindrical tube 10 shown in FIG. 1 is drawn in a cylindrical configuration with an inner lumen 40 defined by an inner exposed surface 34 of the inner layer 32 and extending axially through the tube 10.
  • the inner layer 32 may be disposed within the outer layer 30 by a variety of methods.
  • a preferred method entails co-drawing the inner layer and the outer layer, resulting in a tight, continuous interface 36 between the inner and the outer layer. Details of the co-drawing process may be found in, for instance, Volume 14: Forming and Forging of the Metals Handbook®. Ninth Edition. Copyright 1988 by ASM International.
  • An alternative method involves compression fitting the outer layer onto the inner layer, such as by disposing the inner layer on a fitted mandrel of a preselected shape for support, sliding the outer layer over the inner layer, and subjecting the assembly comprised of the two layers to a compressive force sufficient to collapse the two layers over the mandrel to assume the shape of the mandrel, following which the tubular body thus formed by the two layers can be removed from the mandrel and further processed as described elsewhere in the disclosure.
  • the outer layer 30 preferably is formed from a malleable metallic material that exhibits sufficient strength when expanded to maintain the patency of the vessel wall.
  • a preferred material for the outer layer is stainless steel, which is well suited for intravascular applications due to its biocompatibility and structural strength.
  • Other materials that may be employed in forming the outer layer include cobalt, platinum, iridium, gold, magnesium, titanium, tantalum, and platinum-iridium alloys.
  • the inner layer 32 is formed from an elastic metallic material that will spring back to its original size and shape whenever subjected to a deforming force.
  • the inner layer may therefore be manufactured from spring steel or from alloys exhibiting superelastic or shape memory properties. Articles manufactured from such alloys may be deformed from their original shape into a different configuration that is heat unstable, and upon the application of heat will revert to the original configuration.
  • Certain shape memory alloys including superelastic nickel-titanium (NiTi) (nitinol) or copper-zinc-aluminum (CuZnAl) alloys that are well known in the art, can be deformed through the application of stress to the article of manufacture and will revert to their original shape upon removal of the stress in a phenomenon generally referred to as stress induced martensite (SIM), thereby eliminating the need for alternately cooling and heating the article.
  • SIM shape memory alloys that are stressed at temperatures between where the alloy first begins to transform from austenite to martensite, and the maximum temperature at which martensite can occur, deform elastically up to a critical stress and then continue to deform through the formation of SIM.
  • a SIM shape memory alloy selected for making the inner layer 32 be one that reverts back to austenite at the typical human body temperature of about 36.7 °C (98 °F ).
  • Other materials suitable for forming the inner layer 32 include copper-tin, copper-zinc, copper-zinc-tin, copper-zinc-xenon, copper-aluminum-nickel, copper-gold- zinc, gold-cadmium, gold-copper-zinc, iron beryllium (Fe 3 Be), iron platinum (Fe 3 Pt), indium-thallium, iron-manganese, iron-nickel-titanium-cobalt, nickel-titanium-vanadium, and silver-cadmium.
  • Examples of superelastic and shape memory alloys are found in U.S. Patent No. 4,035,007 to Harrison et al., U.S. Patent No.
  • the final stent is manufactured by cutting out a pattern through the outer and inner layers to form radially expandable elements 50 connected to adjacent elements by interconnecting members 52. Numerous patterns may be cut into the body 10 to form an expandable stent, and FIG. 3 shows an alternative embodiment of such a pattern.
  • U.S. Patent No. 5,514,154 to Lau et al. U.S. Patent No. 5,569,295 to Lam
  • U.S. Patent No. 5,649,952 to Lam U.S. Patent No. 5,728,158 to Lau et al.
  • U.S. Patent No. 5,735,893 to Lau et al. describe such radially expandable stent patterns.
  • expandable elements 50 and 60 preferably are formed out of the body 10 through a laser cutting process, such as the process described in the previously referenced patents, as well as commonly owned U.S. Patent No. 5,759,192 to Saunders.
  • Another preferred method involves chemically etching the tube 10, such as by the process described in U.S. Patent No. 5,735,893 to Lau et al. referenced above.
  • the present invention provides a new and improved stent for maintaining the patency of a body lumen while offering superior resistance to permanent deformation. While the invention has been illustrated and described herein in terms of its use as an intravascular stent, it will be apparent to those skilled in the art that the stent structure disclosed herein can be used to manufacture other types of expandable intravascular devices, such as grafts, filters, and the like. Additionally, the scope of the invention is not limited to a stent with only one layer each of malleable metal and elastic alloy, but rather encompasses the use of tubular structured comprised of multiple layers of such malleable metals and elastic alloys to form stents and other such devices.

Abstract

Composite stent structure defined by openings in a tubular member formed from one or more layers of a biocompatible, malleable metal and one or more layers of a superelastic or a shape memory alloy. The layers are co-drawn or compression-fit together.

Description

COMPOSITE SUPER ELASTIC/SHAPE MEMORY ALLOY AND MALLEABLE ALLOY STENT
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to expandable endoprosthesis devices, generally called stents, that are adapted to be implanted into a patient's body lumen, such as a blood vessel, to maintain the patency thereof. In particular, the invention relates to metallic stents formed from a composite structure comprising discrete layers of super elastic or shape memory alloys and biocompatible, malleable alloys.
Description of the Prior Art
Stents are generally cylindrically shaped devices that function to hold open and sometimes expand a segment of a blood vessel or other anatomical lumen. Stents particularly are suitable for use to support and hold back a dissected arterial lining which can occlude the fluid passageway therethrough, or to maintain the patency of a portion of a blood vessel that has been subjected to an angioplasty procedure.
A variety of devices are known in the art for use as stents and have included coiled wires, slotted tubes, and adjacently connected cylindrical elements in a variety of patterns that are expanded after being placed intraluminaly on a balloon catheter; helically-wound coiled springs manufactured from a thermally expandable metal; and self-expanding stents inserted in a compressed state and subsequently allowed to expand at the intraluminal target site by withdrawing the compressive force, such as provided by an overlying sheath. One of the difficulties encountered using prior stents is providing a stent structure that is longitudinally flexible to easily traverse the tortuous pathways of the human vasculature and which can be readily and uniformly expanded, but that will resist permanent deformation due to the compressive forces exerted by the body lumen itself or by external forces on the body lumen once the stent is deployed and expanded. Resistance to permanent deformation can be especially desirable, for example, in stents deployed within a patient's carotid artery, where a stent may be subjected to additional forces generated by the patient's head and neck movements, or by the pillow, arm, or other head rest used by the patient when sleeping, or by blows to the patient's neck or head.
A number of prior art stents have attempted to address the problem of meeting the various requirements imposed upon them by employing structures comprising different materials selected for their various, desirable physical characteristics. For instance, U.S. Pat. No. 5,749,880 to Banas et al. discloses a stent-graft comprising a tubular stent structure with openings through its wall surfaces to permit radial expansion and circumferentially adjacent layers of polytetrafluoroethylene (ePTFE) covering the inner and outer wall surfaces of the stent. The ePTFE coverings are sintered to the tubular stent to bond around and through the wall surfaces of the tubular stent. Upon expansion of the stent, the ePTFE coverings expand as well to prevent exposing the stent to body tissue or fluids. The goal of this stent therefore is to enhance the biocompatibility of the stent rather than to enhance its mechanical properties.
U.S. Patent No. 5,725,570 to Heath discloses tubular prostheses that are woven from a filament consisting of a metal outer layer with an exposed outer surface and an inner core comprised of a different material than the outer layer. The outer layer is selected from superelastic alloys such as nickel-titanium (nitinol) or stainless steel, and the core is a high density, radiopaque metal such as tantalum. Stents formed from such a filament are said to exhibit substantially the elasticity properties of a solid nitinol filament, but with higher radiopacity. However, such a filament does not impart increased structural strength to the filament, and does not alleviate problems associated with woven wire stents such as lower than desirable crush resistance. Further, the filament experiences a wide range of tension and compression as it is bent during weaving and placement of the stent, as well as during use. These forces are experienced to different degrees by the inner core and the outer layer and could be a potential source of failure due to the different responses exhibited by the dissimilar metals in the core and in the outer layer.
Another type of device is, for example, disclosed in U.S. Patent No. 5,769,882 to Fogarty et al, and comprises essentially a tubular prosthesis body with an overlying sealing layer to provide a fluid-tight seal between the exterior surface of the prosthesis and the inner wall of the body lumen. The tubular body is disclosed as being comprised of two or more different materials, such as organic polymers and metallic elements, to provide different characteristics to the body, such as shape memory, drug delivery, bioabsorbability, and radiopaqueness. The specification discloses that such different materials can be incorporated in a variety of ways, such as different interwoven helices and braids, and include tantalum, nitinol, polyester, and PTFE. Again, this type of device appears limited to woven structures, and is directed to structures wherein the individual filaments are comprised of a single homogeneous material. Further, this type of device does not appear to address the goal of increased structural strength.
In light of the above, it becomes apparent that there remains a need for a stent providing increased structural strength while exhibiting substantial elasticity to resist permanent deformation that might occur during intravascular deployment and use.
SUMMARY OF THE INVENTION
The present invention addresses the above-mentioned needs by providing a tubular stent structure manufactured from a metallic tube comprising one or more layers of a biocompatible, malleable material co-drawn with, or compression fit onto, one or more layers of a superelastic, or shape memory alloy, material. The stent is manufactured by forming various patterns into the wall of the tube to create radially expandable, interconnected elements. The patterns may be formed by various methods, such as laser cutting, mechanical grinding or chemical etching, or a combination of these methods. In use, the stent is introduced into the vasculature of the patient and deployed at the target site using well-known balloon angioplasty techniques. Once expanded, the stent exhibits, due to the malleable material layer, structural strength and crush resistance to support the vascular wall and to maintain the patency of the vessel. The stent additionally exhibits enhanced resistance to permanent deformation due to the superelastic material layer that proceeds to spring back to a predetermined expanded size and shape whenever subjected to a compressive force.
A stent formed according to the method of the present invention provides an axially flexible structure that, when expanded, offers radial strength and superior resistance to permanent deformation. The stent is manufactured economically using known methods and materials, and comprises a significant improvement to the long-term safety of stents and stent-like devices.
BRIEF DESCRIPTION OF THE DRAWINGS
FIGURE 1 is a cross-sectional view depicting a tube for making a stent according to the present invention;
FIG. 2 is a plan view depicting a flattened section of a stent pattern made according to the present invention; and
FIG. 3 is a plan view depicting a flattened section of an alternative embodiment stent pattern made according to the present invention.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
With reference to Figure 1, wherein a preferred embodiment of a tube for manufacturing a stent according to the present invention is shown, a cylindrical tube 10 is comprised of a co-drawn outer layer 30 and an inner layer 32. The embodiment of the cylindrical tube 10 shown in FIG. 1 is drawn in a cylindrical configuration with an inner lumen 40 defined by an inner exposed surface 34 of the inner layer 32 and extending axially through the tube 10.
The inner layer 32 may be disposed within the outer layer 30 by a variety of methods. A preferred method entails co-drawing the inner layer and the outer layer, resulting in a tight, continuous interface 36 between the inner and the outer layer. Details of the co-drawing process may be found in, for instance, Volume 14: Forming and Forging of the Metals Handbook®. Ninth Edition. Copyright 1988 by ASM International. An alternative method involves compression fitting the outer layer onto the inner layer, such as by disposing the inner layer on a fitted mandrel of a preselected shape for support, sliding the outer layer over the inner layer, and subjecting the assembly comprised of the two layers to a compressive force sufficient to collapse the two layers over the mandrel to assume the shape of the mandrel, following which the tubular body thus formed by the two layers can be removed from the mandrel and further processed as described elsewhere in the disclosure.
With continued reference to FIG. 1, the outer layer 30 preferably is formed from a malleable metallic material that exhibits sufficient strength when expanded to maintain the patency of the vessel wall. A preferred material for the outer layer is stainless steel, which is well suited for intravascular applications due to its biocompatibility and structural strength. Other materials that may be employed in forming the outer layer include cobalt, platinum, iridium, gold, magnesium, titanium, tantalum, and platinum-iridium alloys.
The inner layer 32 is formed from an elastic metallic material that will spring back to its original size and shape whenever subjected to a deforming force. The inner layer may therefore be manufactured from spring steel or from alloys exhibiting superelastic or shape memory properties. Articles manufactured from such alloys may be deformed from their original shape into a different configuration that is heat unstable, and upon the application of heat will revert to the original configuration. Certain shape memory alloys, including superelastic nickel-titanium (NiTi) (nitinol) or copper-zinc-aluminum (CuZnAl) alloys that are well known in the art, can be deformed through the application of stress to the article of manufacture and will revert to their original shape upon removal of the stress in a phenomenon generally referred to as stress induced martensite (SIM), thereby eliminating the need for alternately cooling and heating the article. SIM shape memory alloys that are stressed at temperatures between where the alloy first begins to transform from austenite to martensite, and the maximum temperature at which martensite can occur, deform elastically up to a critical stress and then continue to deform through the formation of SIM. When the deforming stress is removed and the alloy is at a temperature above that at which it starts to revert back to austenite, the alloy will attempt to return to its original shape. The temperature at which the alloy begins to revert to the stable austenite phase varies with the composition of the alloy, and it obviously is preferable for the practice of the present invention that a SIM shape memory alloy selected for making the inner layer 32 be one that reverts back to austenite at the typical human body temperature of about 36.7 °C (98 °F ). Other materials suitable for forming the inner layer 32 include copper-tin, copper-zinc, copper-zinc-tin, copper-zinc-xenon, copper-aluminum-nickel, copper-gold- zinc, gold-cadmium, gold-copper-zinc, iron beryllium (Fe3Be), iron platinum (Fe3Pt), indium-thallium, iron-manganese, iron-nickel-titanium-cobalt, nickel-titanium-vanadium, and silver-cadmium. Examples of superelastic and shape memory alloys are found in U.S. Patent No. 4,035,007 to Harrison et al., U.S. Patent No. 4,144,057 to Melton et al., U.S. Patent No. 4,505,767 to Quin, U.S. Patent No. 4,894,100 to Yamauchi, U.S. Patent No. 5,114,504 to AbuJudom et al., and U.S. Patent No. 5,641,364 to Goldberg.
With reference now to FIG. 2, when the inner layer 32 and the outer layer 30 have been joined together to form the body 10, the final stent is manufactured by cutting out a pattern through the outer and inner layers to form radially expandable elements 50 connected to adjacent elements by interconnecting members 52. Numerous patterns may be cut into the body 10 to form an expandable stent, and FIG. 3 shows an alternative embodiment of such a pattern. Co-owned U.S. Patent No. 5,514,154 to Lau et al., U.S. Patent No. 5,569,295 to Lam, U.S. Patent No. 5,591,197 to Orth et al., U.S. Patent No. 5,603,721 to Lau et al., U.S. Patent No. 5,649,952 to Lam, U.S. Patent No. 5,728,158 to Lau et al., and U.S. Patent No. 5,735,893 to Lau et al. describe such radially expandable stent patterns.
With continued reference to FIGS. 2 and 3, expandable elements 50 and 60 preferably are formed out of the body 10 through a laser cutting process, such as the process described in the previously referenced patents, as well as commonly owned U.S. Patent No. 5,759,192 to Saunders. Another preferred method involves chemically etching the tube 10, such as by the process described in U.S. Patent No. 5,735,893 to Lau et al. referenced above.
It will be apparent from the foregoing that the present invention provides a new and improved stent for maintaining the patency of a body lumen while offering superior resistance to permanent deformation. While the invention has been illustrated and described herein in terms of its use as an intravascular stent, it will be apparent to those skilled in the art that the stent structure disclosed herein can be used to manufacture other types of expandable intravascular devices, such as grafts, filters, and the like. Additionally, the scope of the invention is not limited to a stent with only one layer each of malleable metal and elastic alloy, but rather encompasses the use of tubular structured comprised of multiple layers of such malleable metals and elastic alloys to form stents and other such devices. The invention also is not limited to solely the disclosed methods for fitting and/or bonding the layers together, which are merely illustrative of the many practicable possibilities. Further modifications and improvements also may be made without departing from the scope of the invention. Accordingly, it is not intended that the invention be limited, except as by the appended claims.

Claims

WHAT IS CLAIMED IS:
1. A stent for implanting and expanding in a body lumen, comprising: an outer layer formed from a biocompatible, malleable metal and defining a tubular, radially expandable body; and an inner layer formed from a superelastic metal and disposed within the outer layer to define a longitudinal lumen through the tubular body.
2. The stent of claim 1, wherein the malleable metal is selected from the group consisting of stainless steel, cobalt, platinum, iridium, gold, magnesium, titanium, tantalum, and platinum-iridium alloys.
3. The stent of claim 1, wherein the superelastic metal is selected from the group of alloys consisting of copper-tin, copper-zinc, copper-zinc-aluminum, copper-zinc- tin, copper-zinc-xenon, copper-aluminum-nickel, copper-gold-zinc, gold-cadmium, gold- copper-zinc, iron beryllium (Fe3Be), iron platinum (Fe3Pt), indium-thallium, iron- manganese, iron-nickel-titanium-cobalt, nickel-titanium, nickel-titanium-vanadium, and silver-cadmium.
4. The stent of claim 1, wherein the outer layer and the inner layer are co- drawn to form a unitary tube defining the tubular body.
5. The stent of claim 1, wherein the inner layer and the outer layer are co- drawn to form the tubular body.
6. The stent of claim 1, wherein the inner layer is bonded to the outer layer to form the tubular body.
7. The stent of claim 1, wherein the outer layer is compressed onto the inner layer thereby forming an interference fit to form the tubular body.
8. The stent of claim 1, further comprising a plurality of expandable elements defined by laser cuts made in the tubular body.
9. A stent for implanting in a body lumen, comprising: at least one layer formed from a biocompatible, malleable metal with an outer surface and an inner surface to define a tubular, radially expandable body; and at least one layer formed from a superelastic metal and bonded to one of the surfaces of the at least one malleable metal layer.
10. The stent of claim 9, wherein the malleable metal is selected from the group consisting of stainless steel, cobalt, platinum, iridium, gold, magnesium, titanium, tantalum, and platinum-iridium alloys.
11. The stent of claim 9, wherein the superelastic metal is selected from the group of alloys consisting of copper-tin, copper-zinc, copper-zinc-aluminum, copper-zinc- tin, copper-zinc-xenon, copper-aluminum-nickel, copper-gold-zinc, gold-cadmium, gold- copper-zinc, iron beryllium (Fe3Be), iron platinum (Fe3Pt), indium-thallium, iron- manganese, iron-nickel-titanium-cobalt, nickel-titanium, nickel-titanium-vanadium, and silver-cadmium.
12. The stent of claim 9, further comprising a plurality of expandable elements defined by openings formed in the tubular body.
13. A stent for implanting in a body lumen, comprising: alternating layers formed from a first biocompatible, malleable metal and a second, super elastic metal and disposed within one another to define a tubular, radially expandable body with a longitudinal lumen extending therethrough.
14. The stent of claim 13, wherein the malleable metal is selected from the group consisting of stainless steel, cobalt, platinum, iridium, gold, magnesium, titanium, tantalum, and platinum-iridium alloys.
15. The stent of claim 13, wherein the superelastic metal is selected from the group of alloys consisting of copper-tin, copper-zinc, copper-zinc-aluminum, copper-zinc - tin, copper-zinc-xenon, copper-aluminum-nickel, copper-gold-zinc, gold-cadmium, gold- copper-zinc, iron beryllium (Fe3Be), iron platinum (Fe3Pt), indium-thallium, iron- manganese, iron-nickel-titanium-cobalt, nickel-titanium, nickel-titanium-vanadium, and silver-cadmium.
16. The stent of claim 13, wherein the alternating layers are co-drawn as a unitary tube to define the expandable body.
17. The stent of claim 13, wherein the alternating layers are compressed together, thereby forming an interference fit to form the tubular body.
PCT/US2000/004987 1999-02-26 2000-02-25 Composite super elastic/shape memory alloy and malleable alloy stent WO2000050100A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU37091/00A AU3709100A (en) 1999-02-26 2000-02-25 Composite super elastic/shape memory alloy and malleable alloy stent
JP2000600710A JP2002537072A (en) 1999-02-26 2000-02-25 Composite superelastic / shape memory alloy and malleable alloy stents
EP00915894A EP1152775A1 (en) 1999-02-26 2000-02-25 Composite super elastic/shape memory alloy and malleable alloy stent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25980899A 1999-02-26 1999-02-26
US09/259,808 1999-02-26

Publications (1)

Publication Number Publication Date
WO2000050100A1 true WO2000050100A1 (en) 2000-08-31

Family

ID=22986478

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/004987 WO2000050100A1 (en) 1999-02-26 2000-02-25 Composite super elastic/shape memory alloy and malleable alloy stent

Country Status (4)

Country Link
EP (1) EP1152775A1 (en)
JP (1) JP2002537072A (en)
AU (1) AU3709100A (en)
WO (1) WO2000050100A1 (en)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1212986A1 (en) 2000-12-08 2002-06-12 SORIN BIOMEDICA CARDIO S.p.A. An angioplasty stent and manufacturing method thereof
WO2002036045A3 (en) * 2000-10-31 2002-09-12 Scimed Life Systems Inc Endoluminal device having superelastic and plastically deformable sections
US6890350B1 (en) 1999-07-28 2005-05-10 Scimed Life Systems, Inc. Combination self-expandable, balloon-expandable endoluminal device
EP1624828A2 (en) * 2003-05-02 2006-02-15 Gore Enterprise Holdings, Inc. Shape memory alloy articles with improved fatigue performance and methods therefore
WO2007127541A1 (en) * 2006-04-25 2007-11-08 Medtronic Vascular, Inc. Laminated implantable medical device having a metallic coating
US7947135B2 (en) 2007-03-26 2011-05-24 Mx Orthopedics Corp. Proximally self-locking long bone prosthesis
US8052620B2 (en) 2007-05-09 2011-11-08 Japan Science And Technology Agency Guide wire and stent
CN102499800A (en) * 2011-11-17 2012-06-20 苏州大学 Blood vessel stent and preparation method thereof
DE10301850B4 (en) * 2003-01-16 2017-05-04 Dendron Gmbh stent
WO2021224736A1 (en) * 2020-05-04 2021-11-11 V-Wave Ltd. Devices with dimensions that can be reduced and increased in vivo
US11253353B2 (en) 2006-01-23 2022-02-22 V-Wave Ltd. Heart anchor device
US11266501B2 (en) 2004-02-03 2022-03-08 V-Wave Ltd. Device and method for controlling in-vivo pressure
US11291807B2 (en) 2017-03-03 2022-04-05 V-Wave Ltd. Asymmetric shunt for redistributing atrial blood volume
US11458287B2 (en) 2018-01-20 2022-10-04 V-Wave Ltd. Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same
US11497631B2 (en) 2016-05-31 2022-11-15 V-Wave Ltd. Systems and methods for making encapsulated hourglass shaped stents
US11607327B2 (en) 2016-05-31 2023-03-21 V-Wave Ltd. Systems and methods for making encapsulated hourglass shaped stents
US11612385B2 (en) 2019-04-03 2023-03-28 V-Wave Ltd. Systems and methods for delivering implantable devices across an atrial septum
US11690976B2 (en) 2013-05-21 2023-07-04 V-Wave Ltd. Apparatus and methods for delivering devices for reducing left atrial pressure
US11744589B2 (en) 2018-01-20 2023-09-05 V-Wave Ltd. Devices and methods for providing passage between heart chambers
US11813386B2 (en) 2022-04-14 2023-11-14 V-Wave Ltd. Interatrial shunt with expanded neck region
US11850138B2 (en) 2009-05-04 2023-12-26 V-Wave Ltd. Shunt for redistributing atrial blood volume
US11865282B2 (en) 2019-05-20 2024-01-09 V-Wave Ltd. Systems and methods for creating an interatrial shunt

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007319516A (en) * 2006-06-02 2007-12-13 Norikata Taguma Gastrostomy tube using shape memory alloy and its use method
CN108543109B (en) * 2018-03-13 2020-09-18 淮阴工学院 Low-abrasion dual-antibacterial titanium-based nanocomposite bone implant and forming method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0540290A2 (en) * 1991-10-28 1993-05-05 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
EP0809998A2 (en) * 1996-05-28 1997-12-03 Cordis Corporation Composite material endoprosthesis
EP0824900A2 (en) * 1996-08-22 1998-02-25 Advanced Cardiovascular Systems, Inc. Protective coating for a stent with intermediate radiopaque coating
EP0951877A2 (en) * 1998-04-20 1999-10-27 Cordis Corporation A multi-laminate stent having superelastic articulated sections

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0540290A2 (en) * 1991-10-28 1993-05-05 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
EP0809998A2 (en) * 1996-05-28 1997-12-03 Cordis Corporation Composite material endoprosthesis
EP0824900A2 (en) * 1996-08-22 1998-02-25 Advanced Cardiovascular Systems, Inc. Protective coating for a stent with intermediate radiopaque coating
EP0951877A2 (en) * 1998-04-20 1999-10-27 Cordis Corporation A multi-laminate stent having superelastic articulated sections

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890350B1 (en) 1999-07-28 2005-05-10 Scimed Life Systems, Inc. Combination self-expandable, balloon-expandable endoluminal device
WO2002036045A3 (en) * 2000-10-31 2002-09-12 Scimed Life Systems Inc Endoluminal device having superelastic and plastically deformable sections
EP1212986A1 (en) 2000-12-08 2002-06-12 SORIN BIOMEDICA CARDIO S.p.A. An angioplasty stent and manufacturing method thereof
DE10301850B4 (en) * 2003-01-16 2017-05-04 Dendron Gmbh stent
US8177927B2 (en) 2003-05-02 2012-05-15 W. L. Gore & Associates, Inc. Method of making shape memory alloy articles with improved fatigue performance
EP1624828A2 (en) * 2003-05-02 2006-02-15 Gore Enterprise Holdings, Inc. Shape memory alloy articles with improved fatigue performance and methods therefore
EP1624828A4 (en) * 2003-05-02 2011-03-09 Gore Enterprise Holdings Inc Shape memory alloy articles with improved fatigue performance and methods therefore
US8709177B2 (en) 2003-05-02 2014-04-29 W. L. Gore & Associates, Inc. Shape memory alloy articles with improved fatigue performance and methods therefore
US8216396B2 (en) 2003-05-02 2012-07-10 W. L. Gore & Associates, Inc. Shape memory alloy articles with improved fatigue performance and methods therefor
US11382747B2 (en) 2004-02-03 2022-07-12 V-Wave, Ltd. Device and method for controlling in-vivo pressure
US11266501B2 (en) 2004-02-03 2022-03-08 V-Wave Ltd. Device and method for controlling in-vivo pressure
US11253353B2 (en) 2006-01-23 2022-02-22 V-Wave Ltd. Heart anchor device
US7955383B2 (en) 2006-04-25 2011-06-07 Medtronics Vascular, Inc. Laminated implantable medical device having a metallic coating
WO2007127541A1 (en) * 2006-04-25 2007-11-08 Medtronic Vascular, Inc. Laminated implantable medical device having a metallic coating
US8137486B2 (en) 2007-03-26 2012-03-20 Mx Orthopedics, Corp. Proximally self-locking long bone prosthesis
US8062378B2 (en) 2007-03-26 2011-11-22 Mx Orthopedics Corp. Proximal self-locking long bone prosthesis
US8398790B2 (en) 2007-03-26 2013-03-19 Mx Orthopedics, Corp. Proximally self-locking long bone prosthesis
US7947135B2 (en) 2007-03-26 2011-05-24 Mx Orthopedics Corp. Proximally self-locking long bone prosthesis
US8052620B2 (en) 2007-05-09 2011-11-08 Japan Science And Technology Agency Guide wire and stent
US8568470B2 (en) 2007-05-09 2013-10-29 Japan Science And Technology Agency Guide wire and stent
US11850138B2 (en) 2009-05-04 2023-12-26 V-Wave Ltd. Shunt for redistributing atrial blood volume
CN102499800A (en) * 2011-11-17 2012-06-20 苏州大学 Blood vessel stent and preparation method thereof
US11690976B2 (en) 2013-05-21 2023-07-04 V-Wave Ltd. Apparatus and methods for delivering devices for reducing left atrial pressure
US11607327B2 (en) 2016-05-31 2023-03-21 V-Wave Ltd. Systems and methods for making encapsulated hourglass shaped stents
US11497631B2 (en) 2016-05-31 2022-11-15 V-Wave Ltd. Systems and methods for making encapsulated hourglass shaped stents
US11291807B2 (en) 2017-03-03 2022-04-05 V-Wave Ltd. Asymmetric shunt for redistributing atrial blood volume
US11458287B2 (en) 2018-01-20 2022-10-04 V-Wave Ltd. Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same
US11744589B2 (en) 2018-01-20 2023-09-05 V-Wave Ltd. Devices and methods for providing passage between heart chambers
US11612385B2 (en) 2019-04-03 2023-03-28 V-Wave Ltd. Systems and methods for delivering implantable devices across an atrial septum
US11865282B2 (en) 2019-05-20 2024-01-09 V-Wave Ltd. Systems and methods for creating an interatrial shunt
WO2021224736A1 (en) * 2020-05-04 2021-11-11 V-Wave Ltd. Devices with dimensions that can be reduced and increased in vivo
US11813386B2 (en) 2022-04-14 2023-11-14 V-Wave Ltd. Interatrial shunt with expanded neck region

Also Published As

Publication number Publication date
EP1152775A1 (en) 2001-11-14
AU3709100A (en) 2000-09-14
JP2002537072A (en) 2002-11-05

Similar Documents

Publication Publication Date Title
EP1152775A1 (en) Composite super elastic/shape memory alloy and malleable alloy stent
EP1140244B2 (en) Self-expanding prosthesis with biocompatible coating
EP1009326B1 (en) Helical mesh endoprosthesis
US6245100B1 (en) Method for making a self-expanding stent-graft
US6296661B1 (en) Self-expanding stent-graft
US6425915B1 (en) Helical mesh endoprosthesis and methods of use
US7169175B2 (en) Self-expanding stent
EP1481649B1 (en) Flexible self-expandable stent and method of producing the same
US6979349B1 (en) Universal stent link design
EP0782415B1 (en) Permanent shape memory alloy stent
US20120239136A1 (en) Flexible intraluminal stent
EP0758215A1 (en) Stent and method of making the same
WO2009120458A2 (en) Stent prosthesis having select flared crowns
US7264633B2 (en) Anvil bridge stent design
US5938695A (en) Coronary endoprothesis such as a stent
CA2459516C (en) Split-bridge stent design
EP3242641A1 (en) Endoluminal stent
CA2538001C (en) Non-foreshortening intraluminal prosthesis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2000915894

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 600710

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 2000915894

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000915894

Country of ref document: EP